# Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study

> **NCT01018134** · PHASE2 · COMPLETED · sponsor: **Sun Pharmaceutical Industries, Inc.** · enrollment: 151 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Desoximetasone 0.05% once daily
- **DRUG:** Desoximetasone 0.05% twice daily
- **DRUG:** Desoximetasone 0.25% once daily
- **DRUG:** Desoximetasone 0.25% once daily
- **DRUG:** Vehicle once daily
- **DRUG:** Vehicle twice daily

## Key facts

- **NCT ID:** NCT01018134
- **Lead sponsor:** Sun Pharmaceutical Industries, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2014-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01018134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01018134, "Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01018134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*